By: Andrew Smith
The National Institute of Allergy and Infectious Diseases (NIAID) has earmarked $600 million to stop future pandemics before they start – and up to $3.8 million of that will go to a team led by Rutgers researcher Eddy Arnold.
The plan is simple: Identify viruses with the potential to drive future pandemics and develop treatments for them now. To do this, hundreds of researchers from dozens of institutions are collaborating on cutting-edge science.
Arnold, a resident faculty member at the Center for Advanced Biotechnology and Medicine (CABM), and his colleague Martin Blaser, the director of CABM, sat down with Rutgers Today to explain the overall effort and how Rutgers will contribute. Read Rutgers Today article here.